NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Carson S, McDonagh MS, Thakurta S, et al. Drug Class Review: Newer Drugs for Insomnia: Final Report Update 2 [Internet]. Portland (OR): Oregon Health & Science University; 2008 Oct.
This publication is provided for historical reference only and the information may be out of date.
Evidence Table 1. Characteristics of head-to-head trials of newer insomnia drugs
Evidence Table 2. Results of head-to-head trials of newer insomnia drugs
Evidence Table 3. Characteristics of Placebo-controlled trials of newer insomnia drugs
Evidence Table 4. Results of placebo-controlled trials of newer insomnia drugs
Evidence Table 5. Characteristics of active control trials of newer insomnia drugs
Evidence Table 6. Results of active control trials of newer insomnia drugs
Evidence Table 7. Adverse events reported in trials of newer insomnia drugs
Evidence Table 8a. Quality assessment of randomized controlled trials of newer drugs for insomnia
Evidence Table 8b. Quality assessment of randomized controlled trials (new for Update #2)
- Evidence Tables - Drug Class Review: Newer Drugs for InsomniaEvidence Tables - Drug Class Review: Newer Drugs for Insomnia
Your browsing activity is empty.
Activity recording is turned off.
See more...